Best Practices in the Diagnosis and Treatment of Amyotrophic Lateral Sclerosis (ALS)

Activity Overview

Amyotrophic lateral sclerosis (ALS) can be challenging to diagnose, particularly early in the disease course. As a result, diagnostic delay is common, which often leads to missed opportunities for disease-modifying treatment. Although disease management remains largely symptomatic and palliative, new therapies with the potential to improve patient outcomes are emerging. In this program, an ALS expert will discuss strategies to support earlier identification and confirmatory testing, as well as insights into current and emerging ALS therapies. This activity is recorded from the live event held on September 19, 2026.

Target Audience

This activity is intended for neuromuscular specialists, neurologists, nurse practitioners, physician assistants, and nurses who treat neuromuscular diseases.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Identify the diverse manifestations of amyotrophic lateral sclerosis
• Demonstrate knowledge of best practices in the diagnosis of amyotrophic lateral sclerosis
• Discuss the potential role of new and emerging disease-modifying treatments in the management of amyotrophic lateral sclerosis

The staff of Physicians’ Education Resource^®, LLC have no relevant financial relationships with ineligible companies.

PER^® mitigated all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This accredited continuing education activity was planned in accordance with the ACCME Standards for Integrity and Independence to ensure balance, objectivity, independence, and scientific rigor. Faculty were instructed to use generic names when possible and to base recommendations on the best available evidence. Proprietary product names may be referenced in clinical discussion for educational purposes only and do not imply endorsement.

This activity may include discussion of investigational, unapproved, or off‑label uses of drugs or devices. Learners are advised to consult prescribing information for products discussed. Content is provided for educational purposes only and is not a substitute for the independent clinical judgment of a health care professional. Learners are encouraged to critically evaluate the information presented and apply their own clinical judgment.

The views expressed are those of the individual faculty members and do not necessarily reflect the views of the accredited provider or any entity providing commercial support.

This activity may have used AI-assisted tools to support educational development. All content was reviewed and approved by qualified faculty or planners. The accredited provider retains full responsibility for accuracy, balance, and independence.